Distinguished in Angina

Philip D. Adamson

South Island, 
Christchurch, CAN, NZ 
Distinguished in Angina
South Island, 
Christchurch, CAN, NZ 
OverviewLocationsClinical Research

Overview

Philip Adamson practices in Christchurch, New Zealand. Mr. Adamson is rated as a Distinguished expert by MediFind in the treatment of Angina. His top areas of expertise are Stable Angina, Angina, Coronary Heart Disease, Heart Attack, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 139 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Angina.

Gender
Male

Locations

South Island, Christchurch, CAN, New Zealand
Other Locations
2 Riccarton Avenue, Christchurch, CAN 8011, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction
Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction
Enrollment Status: Completed
Publish Date: March 17, 2025
Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease
Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease
Enrollment Status: Completed
Publish Date: May 10, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

139 Total Publications

Machine learning to predict high-risk coronary artery disease on CT in the SCOT-HEART trial.
Machine learning to predict high-risk coronary artery disease on CT in the SCOT-HEART trial.
Journal: Open heart
Published: July 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Adamson's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile